Tretinoin - Lypro BiosciencesAlternative Names: All trans retinoic acid - Lypro Biosciences; ATRA-ND; ATRA-tND
Latest Information Update: 01 Aug 2016
At a glance
- Originator Lypro Biosciences
- Class Antiacnes; Antineoplastics; Keratolytics; Retinoids; Small molecules
- Mechanism of Action Protein synthesis inhibitors; Retinoic acid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Mantle-cell lymphoma
Most Recent Events
- 01 Aug 2016 Chemical structure information added
- 26 Jul 2016 Early research is ongoing in USA